Investing
The funding brings the company's total raise to $60 million.
The company’s platform, OncoGaze, analyzes genomic biomarkers from routine clinical slides to help clinicians select personalized therapies.
Also, 4DMedical has raised $57 million and obtained clearance to expand across Europe.
Mediwhale has recently raised $13 million in Series C funding, which will also support its entry into the United States market.
The company will use the funds to expand its clinical agent platform and grow its partnerships with care organizations.
The funds will be used to expand access to its AI therapist assistant Sage that provides 24/7 clinically supervised mental health support to patients between therapy sessions.
The company will use the funds to expand its presence globally and enhance its platform.
The company will use the funds to expand its agentic AI platform and fund new models for employers, including access to GLP-1 medications.
AI revenue cycle management platform Adonis raises $40 million and Blossom Health, a telehealth platform for psychiatry, garners $20 million.
The company aims to help health systems deploy, govern and scale generative AI across clinical care and administrative workflows.